All News

    What Role May ctDNA Have in Melanoma Management?

    April 11th 2025, 1:00pm

    Article

    CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.

    An Expert Breaks Down Lymphedema Following Cancer Care

    April 10th 2025, 9:00pm

    Video

    Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.

    Melanoma Taught Me Faith, Gratitude and That Nothing Is Permanent

    April 10th 2025, 8:00pm

    Article

    I was diagnosed with stage 3 melanoma at 31, faced recurrence and now share my journey to raise awareness, stay hopeful and trust in God’s plan.

    FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types

    April 10th 2025, 7:00pm

    Article

    The FDA has approved Jobevne, a biosimilar to Avastin, for IV use in a number of cancer types.

    Managing Cancer Demands With Flexibility and a Strategic Mindset

    April 10th 2025, 5:00pm

    Article

    It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and patience.

    FDA Grants Full Approval to Vitrakvi For NTRK-Positive Solid Tumors

    April 10th 2025, 2:47pm

    Article

    Vitrakvi, first granted accelerated approval in 2018, has received full approval from the FDA.

    Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award

    April 10th 2025, 1:15pm

    Article

    The 2025 Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impact.

    First Patient Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors

    April 9th 2025, 9:00pm

    Article

    CT-95 is being developed for cancers including pancreatic, ovarian and mesothelioma and other solid tumors.

    Early Detection and Screening is Key for Esophageal Cancer

    April 9th 2025, 8:29pm

    Video

    Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.

    Breaking Down Treatment Options for Patients With Head and Neck Cancer

    April 9th 2025, 7:00pm

    Article

    Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.